联合治疗-话题@MedSci

#联合治疗#

277篇内容 | 4214人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1313642, encodeId=75b013136427c, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=PD-L1免疫治疗药物avelumab牵手表观药物entinostat，联合治疗卵巢癌研究启动, objectType=article, longId=61803, objectId=98bd618032f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98bd618032f, replyNumber=0, likeNumber=33, createdTime=2016-01-09, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98bd618032f, moduleTitle=PD-L1免疫治疗药物avelumab牵手表观药物entinostat，联合治疗卵巢癌研究启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98bd618032f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313641, encodeId=3d8f131364124, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=应用膜覆盖支架和Taxus支架联合治疗CABG术后LAD长病（图）, objectType=article, longId=59952, objectId=f17759952ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f17759952ea, replyNumber=0, likeNumber=45, createdTime=2015-12-04, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f17759952ea, moduleTitle=应用膜覆盖支架和Taxus支架联合治疗CABG术后LAD长病（图）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f17759952ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313640, encodeId=67f3131364092, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, objectType=article, longId=58515, objectId=c3125851569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3125851569, replyNumber=0, likeNumber=58, createdTime=2015-11-10, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3125851569, moduleTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3125851569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313639, encodeId=df6313136392c, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=NEJM：来那度胺+利妥昔单抗联合治疗套细胞淋巴瘤, objectType=article, longId=58384, objectId=e0de5838437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0de5838437, replyNumber=0, likeNumber=69, createdTime=2015-11-07, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0de5838437, moduleTitle=NEJM：来那度胺+利妥昔单抗联合治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0de5838437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313638, encodeId=94cb131363884, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加, objectType=article, longId=58165, objectId=68165816523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68165816523, replyNumber=0, likeNumber=60, createdTime=2015-11-03, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68165816523, moduleTitle=J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68165816523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313637, encodeId=c023131363e18, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=NEJM：安贝生坦和他达拉非初始联合治疗肺动脉高压已见成效, objectType=article, longId=55405, objectId=d8585540525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8585540525, replyNumber=0, likeNumber=113, createdTime=2015-08-28, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8585540525, moduleTitle=NEJM：安贝生坦和他达拉非初始联合治疗肺动脉高压已见成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8585540525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313636, encodeId=ba8f131363647, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=NEJM：急性冠脉综合征后应用依折麦布-他汀类药物联合治疗, objectType=article, longId=51643, objectId=64455164382, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64455164382, replyNumber=0, likeNumber=75, createdTime=2015-06-06, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64455164382, moduleTitle=NEJM：急性冠脉综合征后应用依折麦布-他汀类药物联合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64455164382)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313635, encodeId=82701313635e3, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Lancet：dabrafenib和trametinib联合治疗Val6000 BRAF突变的黑色素瘤, objectType=article, longId=51556, objectId=04735155643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04735155643, replyNumber=0, likeNumber=117, createdTime=2015-06-04, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04735155643, moduleTitle=Lancet：dabrafenib和trametinib联合治疗Val6000 BRAF突变的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04735155643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313634, encodeId=2a1b1313634d4, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤, objectType=article, longId=51511, objectId=fde1515116c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde1515116c, replyNumber=0, likeNumber=60, createdTime=2015-06-03, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde1515116c, moduleTitle=NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde1515116c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313633, encodeId=e08113136331a, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Clin Cancer Res：IPH2101和来那度胺联合治疗复发/难治多发性骨髓瘤的I期试验, objectType=article, longId=51252, objectId=4d1a51252bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1a51252bf, replyNumber=0, likeNumber=74, createdTime=2015-05-28, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1a51252bf, moduleTitle=Clin Cancer Res：IPH2101和来那度胺联合治疗复发/难治多发性骨髓瘤的I期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1a51252bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313632, encodeId=126113136321b, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=The Lancet：苯丁酸氮芥和奥法木单抗联合治疗是CLL的更好的选择, objectType=article, longId=49347, objectId=2a5e4934e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a5e4934e74, replyNumber=0, likeNumber=62, createdTime=2015-04-16, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a5e4934e74, moduleTitle=The Lancet：苯丁酸氮芥和奥法木单抗联合治疗是CLL的更好的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a5e4934e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313631, encodeId=ce5f131363148, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Lancet Oncol：多药联合治疗前列腺癌的一项研究, objectType=article, longId=47778, objectId=78044e778ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78044e778ce, replyNumber=0, likeNumber=51, createdTime=2015-03-07, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78044e778ce, moduleTitle=Lancet Oncol：多药联合治疗前列腺癌的一项研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78044e778ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313630, encodeId=852913136309e, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=NEJM：Dabrafenib 和Trametinib联合治疗能有效提高恶性黑色素瘤患者的总生存, objectType=article, longId=44919, objectId=ce724491956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce724491956, replyNumber=0, likeNumber=57, createdTime=2015-01-03, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce724491956, moduleTitle=NEJM：Dabrafenib 和Trametinib联合治疗能有效提高恶性黑色素瘤患者的总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce724491956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313629, encodeId=5dc2131362989, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Onco Targets Ther：贝伐单抗+紫杉醇联合治疗对HER2-乳腺癌患者安全有效, objectType=article, longId=43821, objectId=abce43821a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abce43821a6, replyNumber=0, likeNumber=85, createdTime=2014-12-11, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abce43821a6, moduleTitle=Onco Targets Ther：贝伐单抗+紫杉醇联合治疗对HER2-乳腺癌患者安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abce43821a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313628, encodeId=b6141313628c5, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=BJC：HIF-1α预测膀胱癌受益于CON联合治疗, objectType=article, longId=38541, objectId=f9bb3854145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9bb3854145, replyNumber=0, likeNumber=57, createdTime=2014-08-03, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9bb3854145, moduleTitle=BJC：HIF-1α预测膀胱癌受益于CON联合治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9bb3854145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313627, encodeId=e8aa131362e70, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=Diabetes Obes Metab：早期联合治疗可获得更佳的降糖疗效, objectType=article, longId=36176, objectId=5e38361e647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e38361e647, replyNumber=0, likeNumber=76, createdTime=2014-06-11, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e38361e647, moduleTitle=Diabetes Obes Metab：早期联合治疗可获得更佳的降糖疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e38361e647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313626, encodeId=f6e9131362619, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=JNS：前后联合治疗胸腰段粉碎骨折长期效果好, objectType=article, longId=36108, objectId=dc373610822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc373610822, replyNumber=0, likeNumber=58, createdTime=2014-06-08, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc373610822, moduleTitle=JNS：前后联合治疗胸腰段粉碎骨折长期效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc373610822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313625, encodeId=fb3613136253c, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=JTO：雌激素加孕激素联合治疗优于单一治疗, objectType=article, longId=33852, objectId=2e9c33852f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e9c33852f2, replyNumber=0, likeNumber=91, createdTime=2014-04-27, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e9c33852f2, moduleTitle=JTO：雌激素加孕激素联合治疗优于单一治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e9c33852f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313624, encodeId=231d13136243a, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=刘靖&胡大一：从2013欧洲高血压指南看联合治疗新趋势, objectType=article, longId=31357, objectId=b9923135ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9923135ee8, replyNumber=0, likeNumber=83, createdTime=2014-03-02, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9923135ee8, moduleTitle=刘靖&胡大一：从2013欧洲高血压指南看联合治疗新趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9923135ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1313623, encodeId=92081313623f8, content=<a href='/topic/show?id=d4cc80e128f' target=_blank style='color:#2F92EE;'>#联合治疗#</a>, objectTitle=GCS 2014：Ramucirumab联合治疗可改善转移性胃癌总生存, objectType=article, longId=29826, objectId=512a298266a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512a298266a, replyNumber=0, likeNumber=70, createdTime=2014-01-24, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512a298266a, moduleTitle=GCS 2014：Ramucirumab联合治疗可改善转移性胃癌总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=512a298266a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

联合治疗

2020-05-29

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

PD-L1免疫治疗药物avelumab牵手表观药物entinostat，联合治疗卵巢癌研究启动

2016-01-09

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

应用膜覆盖支架和Taxus支架联合治疗CABG术后LAD长病（图）

2015-12-04

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析

2015-11-10

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

NEJM：来那度胺+利妥昔单抗联合治疗套细胞淋巴瘤

2015-11-07

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加

2015-11-03

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

NEJM：安贝生坦和他达拉非初始联合治疗肺动脉高压已见成效

2015-08-28

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

NEJM：急性冠脉综合征后应用依折麦布-他汀类药物联合治疗

2015-06-06

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Lancet：dabrafenib和trametinib联合治疗Val6000 BRAF突变的黑色素瘤

2015-06-04

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

NEJM：Nivolumab和易普利姆玛联合治疗或单药治疗黑色素瘤

2015-06-03

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Clin Cancer Res：IPH2101和来那度胺联合治疗复发/难治多发性骨髓瘤的I期试验

2015-05-28

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

The Lancet：苯丁酸氮芥和奥法木单抗联合治疗是CLL的更好的选择

2015-04-16

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Lancet Oncol：多药联合治疗前列腺癌的一项研究

2015-03-07

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

NEJM：Dabrafenib 和Trametinib联合治疗能有效提高恶性黑色素瘤患者的总生存

2015-01-03

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Onco Targets Ther：贝伐单抗+紫杉醇联合治疗对HER2-乳腺癌患者安全有效

2014-12-11

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

BJC：HIF-1α预测膀胱癌受益于CON联合治疗

2014-08-03

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

Diabetes Obes Metab：早期联合治疗可获得更佳的降糖疗效

2014-06-11

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

JNS：前后联合治疗胸腰段粉碎骨折长期效果好

2014-06-08

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

JTO：雌激素加孕激素联合治疗优于单一治疗

2014-04-27

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

刘靖&胡大一：从2013欧洲高血压指南看联合治疗新趋势

2014-03-02

zhaozuguo (审核中...)

前往app查看评论内容

#联合治疗#

GCS 2014：Ramucirumab联合治疗可改善转移性胃癌总生存

2014-01-24

科室
- - 订阅+
  - 更多科室
工具
服务